Impact of fludarabine exposure on overall survival in patients receiving fludarabine/cyclophosphamide reduced intensity conditioning hematopoietic cell transplantation for hematologic malignancies

B Adhikari; K Schmidt; A Carpenter; W Trang; I Kraft; W Figg; S Pavletic; Eduard Schulz; N El Jurdi

doi:10.1182/blood-2025-5979

Impact of fludarabine exposure on overall survival in patients receiving fludarabine/cyclophosphamide reduced intensity conditioning hematopoietic cell transplantation for hematologic malignancies

B Adhikari
, K Schmidt
, A Carpenter
, W Trang
, I Kraft
, W Figg
, S Pavletic
, Eduard Schulz
, N El Jurdi

Klinische Abteilung für Hämatologie

Publikation: Beitrag in Fachzeitschrift › Konferenzabstract

Originalsprache	Englisch
Fachzeitschrift	Blood
DOIs	https://doi.org/10.1182/blood-2025-5979
Publikationsstatus	Veröffentlicht - 2025
Veranstaltung	67th Annual Meeting of the American-Society-of-Hematology (ASH) - Orlando, USA/Vereinigte Staaten Dauer: 6 Dez. 2025 → 9 Dez. 2025

Wissenschaftszweige

301 Medizinisch-theoretische Wissenschaften, Pharmazie
302 Klinische Medizin

Zugriff auf Dokument

10.1182/blood-2025-5979

Andere Dateien und Links

Web of Science

Impact of fludarabine exposure on overall survival in patients receiving fludarabine/cyclophosphamide reduced intensity conditioning hematopoietic cell transplantation for hematologic malignancies
Adhikari, B. (Autor*in), Schmidt, K. (Autor*in), Carpenter, A. (Autor*in), Trang, W. (Autor*in), Kraft, I. (Autor*in), Figg, W. (Autor*in), Pavletic, S. (Autor*in), Schulz, E. (Autor*in) & El Jurdi, N. (Autor*in)
2025
Aktivität: Vortrag oder Poster › Poster

Dieses zitieren

@article{b69f159b64414d179ffa9569be8aa67f,

title = "Impact of fludarabine exposure on overall survival in patients receiving fludarabine/cyclophosphamide reduced intensity conditioning hematopoietic cell transplantation for hematologic malignancies",

author = "B Adhikari and K Schmidt and A Carpenter and W Trang and I Kraft and W Figg and S Pavletic and Eduard Schulz and \{El Jurdi\}, N",

year = "2025",

doi = "10.1182/blood-2025-5979",

language = "English",

journal = "Blood",

issn = "0006-4971",

publisher = "Elsevier B.V.",

note = "67th Annual Meeting of the American-Society-of-Hematology (ASH) ; Conference date: 06-12-2025 Through 09-12-2025",

}

TY - JOUR

T1 - Impact of fludarabine exposure on overall survival in patients receiving fludarabine/cyclophosphamide reduced intensity conditioning hematopoietic cell transplantation for hematologic malignancies

AU - Adhikari, B

AU - Schmidt, K

AU - Carpenter, A

AU - Trang, W

AU - Kraft, I

AU - Figg, W

AU - Pavletic, S

AU - Schulz, Eduard

AU - El Jurdi, N

PY - 2025

Y1 - 2025

UR - https://www.webofscience.com/wos/woscc/full-record/WOS:1665029500029

U2 - 10.1182/blood-2025-5979

DO - 10.1182/blood-2025-5979

M3 - Conference abstract

SN - 0006-4971

JO - Blood

JF - Blood

T2 - 67th Annual Meeting of the American-Society-of-Hematology (ASH)

Y2 - 6 December 2025 through 9 December 2025

ER -

Impact of fludarabine exposure on overall survival in patients receiving fludarabine/cyclophosphamide reduced intensity conditioning hematopoietic cell transplantation for hematologic malignancies

Wissenschaftszweige

Zugriff auf Dokument

Andere Dateien und Links

Aktivitäten

Impact of fludarabine exposure on overall survival in patients receiving fludarabine/cyclophosphamide reduced intensity conditioning hematopoietic cell transplantation for hematologic malignancies

Dieses zitieren